Vihanga Pahalawatta is a notable inventor based in Des Plaines, IL (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection and analysis of tuberculosis.

Latest Patents

Pahalawatta holds 5 patents that focus on innovative methods for identifying and diagnosing tuberculosis. His latest patents include "Compositions and methods for the detection and analysis of MTB," which provides compositions and methods useful for the detection of Mycobacterium tuberculosis (MTB). This patent outlines kits, reagents, and methods for nucleic acid amplification and detection procedures that specifically and sensitively detect MTB in samples. Another significant patent is "Compositions and methods for identifying drug resistant tuberculosis," which details compositions and methods for diagnosing and characterizing tuberculosis infections, particularly focusing on identifying drug-resistant strains.

Career Highlights

Vihanga Pahalawatta is currently associated with Abbott Molecular Inc., a leading company in molecular diagnostics. His work at Abbott has been pivotal in advancing the technologies used for tuberculosis detection and treatment.

Collaborations

Pahalawatta has collaborated with notable colleagues, including Ning Tang and Gregor W Leckie, to further enhance the research and development of diagnostic methods for tuberculosis.

Conclusion

Vihanga Pahalawatta's innovative work in tuberculosis detection has made a significant impact on medical diagnostics. His contributions continue to advance the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.